Leslie Shaw to Kidney Transplantation
This is a "connection" page, showing publications Leslie Shaw has written about Kidney Transplantation.
Connection Strength
2.083
-
Chan L, Hartmann E, Cibrik D, Cooper M, Shaw LM. Optimal everolimus concentration is associated with risk reduction for acute rejection in de novo renal transplant recipients. Transplantation. 2010 Jul 15; 90(1):31-7.
Score: 0.284
-
Kaplan B, Gaston RS, Meier-Kriesche HU, Bloom RD, Shaw LM. Mycophenolic acid exposure in high- and low-weight renal transplant patients after dosing with mycophenolate mofetil in the Opticept trial. Ther Drug Monit. 2010 Apr; 32(2):224-7.
Score: 0.278
-
van Gelder T, Shaw LM. The rationale for and limitations of therapeutic drug monitoring for mycophenolate mofetil in transplantation. Transplantation. 2005 Oct 15; 80(2 Suppl):S244-53.
Score: 0.204
-
Shaw LM, Korecka M, DeNofrio D, Brayman KL. Pharmacokinetic, pharmacodynamic, and outcome investigations as the basis for mycophenolic acid therapeutic drug monitoring in renal and heart transplant patients. Clin Biochem. 2001 Feb; 34(1):17-22.
Score: 0.148
-
Shaw LM, Korecka M, Aradhye S, Grossman R, Bayer L, Innes C, Cucciara A, Barker C, Naji A, Nicholls A, Brayman K. Mycophenolic acid area under the curve values in African American and Caucasian renal transplant patients are comparable. J Clin Pharmacol. 2000 Jun; 40(6):624-33.
Score: 0.141
-
Shaw LM, Nicholls A, Hale M, Armstrong VW, Oellerich M, Yatscoff R, Morris RE, Holt DW, Venkataramanan R, Haley J, Halloran P, Ettenger R, Keown P, Morris RG. Therapeutic monitoring of mycophenolic acid. A consensus panel report. Clin Biochem. 1998 Jul; 31(5):317-22.
Score: 0.123
-
Shaw LM. Mycophenolate mofetil: pharmacokinetic strategies for optimizing immunosuppression. Drug Metabol Drug Interact. 1997; 14(1):33-40.
Score: 0.111
-
Shaw LM, Annesley T, Gilmore B, Brayman K. Measurement of OG37-325 by high-performance liquid chromatography. Transplant Proc. 1994 Oct; 26(5):3010-2.
Score: 0.095
-
Shaw LM, Audet PR, Grossman RA, Fields L, Lensmeyer GL, Dafoe DC. Adjustment of cyclosporine dosage in renal transplant patients based on concentration measured specifically in whole blood: clinical outcome results and diagnostic utility. Transplant Proc. 1990 Jun; 22(3):1267-73.
Score: 0.070
-
de Winter BC, van Gelder T, Sombogaard F, Shaw LM, van Hest RM, Mathot RA. Pharmacokinetic role of protein binding of mycophenolic acid and its glucuronide metabolite in renal transplant recipients. J Pharmacokinet Pharmacodyn. 2009 Dec; 36(6):541-64.
Score: 0.068
-
Gaston RS, Kaplan B, Shah T, Cibrik D, Shaw LM, Angelis M, Mulgaonkar S, Meier-Kriesche HU, Patel D, Bloom RD. Fixed- or controlled-dose mycophenolate mofetil with standard- or reduced-dose calcineurin inhibitors: the Opticept trial. Am J Transplant. 2009 Jul; 9(7):1607-19.
Score: 0.066
-
van Hest RM, van Gelder T, Vulto AG, Shaw LM, Mathot RA. Pharmacokinetic modelling of the plasma protein binding of mycophenolic acid in renal transplant recipients. Clin Pharmacokinet. 2009; 48(7):463-76.
Score: 0.064
-
Chan L, Greenstein S, Hardy MA, Hartmann E, Bunnapradist S, Cibrik D, Shaw LM, Munir L, Ulbricht B, Cooper M. Multicenter, randomized study of the use of everolimus with tacrolimus after renal transplantation demonstrates its effectiveness. Transplantation. 2008 Mar 27; 85(6):821-6.
Score: 0.061
-
Meier-Kriesche HU, Shaw LM, Korecka M, Kaplan B. Pharmacokinetics of mycophenolic acid in renal insufficiency. Ther Drug Monit. 2000 Feb; 22(1):27-30.
Score: 0.034
-
Kaplan B, Meier-Kriesche HU, Friedman G, Mulgaonkar S, Gruber S, Korecka M, Brayman KL, Shaw LM. The effect of renal insufficiency on mycophenolic acid protein binding. J Clin Pharmacol. 1999 Jul; 39(7):715-20.
Score: 0.033
-
Oellerich M, Armstrong VW, Sch?tz E, Shaw LM. Therapeutic drug monitoring of cyclosporine and tacrolimus. Update on Lake Louise Consensus Conference on cyclosporin and tacrolimus. Clin Biochem. 1998 Jul; 31(5):309-16.
Score: 0.031
-
Shaw LM, Korecka M, van Breeman R, Nowak I, Brayman KL. Analysis, pharmacokinetics and therapeutic drug monitoring of mycophenolic acid. Clin Biochem. 1998 Jul; 31(5):323-8.
Score: 0.031
-
Schulman SL, Shaw LM, Jabs K, Leonard MB, Brayman KL. Interaction between tacrolimus and chloramphenicol in a renal transplant recipient. Transplantation. 1998 May 27; 65(10):1397-8.
Score: 0.031
-
Shaw LM, Mick R, Nowak I, Korecka M, Brayman KL. Pharmacokinetics of mycophenolic acid in renal transplant patients with delayed graft function. J Clin Pharmacol. 1998 Mar; 38(3):268-75.
Score: 0.030
-
Shaw LM, Kaplan B, Brayman KL. Prospective investigations of concentration-clinical response for immunosuppressive drugs provide the scientific basis for therapeutic drug monitoring. Clin Chem. 1998 Feb; 44(2):381-7.
Score: 0.030
-
Weber M, Deng S, Arenas J, Aradhye S, Grossman R, Shaw L, Naji A, Barker C, Brayman KL. Decreased rejection episodes in African-American renal transplant recipients receiving mycophenolate mofetil/tacrolimus therapy. Transplant Proc. 1997 Dec; 29(8):3669-70.
Score: 0.030
-
Salm P, Taylor PJ, Clark A, Balderson GA, Grygotis A, Norris RL, Lynch SV, Shaw LM, Pond SM. High-performance liquid chromatography-tandem mass spectrometry as a reference for analysis of tacrolimus to assess two immunoassays in patients with liver and renal transplants. Ther Drug Monit. 1997 Dec; 19(6):694-700.
Score: 0.030
-
Weber M, Ketchum RJ, Sellers M, Aradhye S, Deng S, Grossman R, Shaw L, Naji A, Barker C, Brayman KL. Single center analysis of mycophenolate mofetil and Neoral/prednisone therapy for prophylaxis of rejection in African-American and Caucasian transplant recipients. Transplant Proc. 1997 Feb-Mar; 29(1-2):338-9.
Score: 0.028
-
Heifets M, Cooney GF, Shaw LM, Libetti G. Diurnal variation of cyclosporine clearance in stable renal transplant recipients receiving continuous infusion. Transplantation. 1995 Dec 27; 60(12):1615-7.
Score: 0.026
-
Cooney GF, Heifets M, Bell A, Shaw LM, LiBetti G. Utility of pretransplantation cyclosporine pharmacokinetic studies. Ther Drug Monit. 1994 Apr; 16(2):151-4.
Score: 0.023
-
Shipkova M, Niedmann PD, Armstrong VW, Sch?tz E, Wieland E, Shaw LM, Oellerich M. Simultaneous determination of mycophenolic acid and its glucuronide in human plasma using a simple high-performance liquid chromatography procedure. Clin Chem. 1998 Jul; 44(7):1481-8.
Score: 0.008
-
Holt DW, Johnston A, Marsden JT, Vernillet L, Keown PA, Rosano TG, Shaw LM, Rosenthaler J. Monoclonal antibodies for radioimmunoassay of cyclosporine: a multicenter comparison of their performance with the Sandoz polyclonal radioimmunoassay kit. Clin Chem. 1988 Jun; 34(6):1091-6.
Score: 0.004
-
Kahn GC, Shaw LM, Kane MD. Routine monitoring of cyclosporine in whole blood and in kidney tissue using high performance liquid chromatography. J Anal Toxicol. 1986 Jan-Feb; 10(1):28-34.
Score: 0.003